The phosphoramidites market shows promising growth in oligonucleotide synthesis, key to gene therapy and personalized ...
As part of the collaboration, Secarna will leverage its proprietary, AI-empowered OligoCreator® discovery and development platform to identify promising oligonucleotide candidates, applying both ...
New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Oligonucleotide Therapy Global Market Report 2023" - https://www ...
Oligonucleotide (oligo) therapies are gaining momentum due to their broad applications in diagnostics, therapeutics, research, and personalized medicine. These treatments offer precise, ...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide ...
The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its MassHunter BioConfirm 12.0 software, which now supports data generated by Agilent ...
News-Medical.Net on MSN
Picoquant invests in Fluobrick Solutions to simplify access to single molecule research
PicoQuant GmbH announces its investment in FluoBrick Solutions GmbH, a newly founded Berlin-based start-up focused on giving ...
The global oligonucleotide API market is poised to grow from USD 2.81 billion in 2024 to USD 4.84 billion by 2034, expanding at a CAGR of 5.60%. The increasing need for innovative drug classes and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback